|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/50 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/48 | (2006.01) |
| (11) | Number of the document | 2817000 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13704974.8 |
| Date of filing the European patent application | 2013-02-21 | |
| (97) | Date of publication of the European application | 2014-12-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
| (46) | Date of publication of the claims translation | 2021-11-10 |
| (86) | Number | PCT/EP2013/053426 |
| Date | 2013-02-21 |
| (87) | Number | WO 2013/124340 |
| Date | 2013-08-29 |
| (30) | Number | Date | Country code |
| 461MU2012 | 2012-02-21 | IN |
| (72) |
PILGAONKAR, Pratibha S. , IN
RUSTOMJEE, Maharukh T. , IN
GANDHI, Anilkumar S. , IN
|
| (73) |
TOWA PHARMACEUTICAL EUROPE, S.L. ,
Carrer de Sant Martí, 75-97, 08107 Martorelles Barcelona,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Peroralinės dabigatrano eteksilato farmacinės kompozicijos |
| ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE |
| Payment date | Validity (years) | Amount | |
| 2024-01-31 | 12 | 289.00 EUR |
| 2025-02-21 |